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Abstract: The distribution and determinants of cancerous diseases in specified 
populations attempts to prevent and control cancer-related public health issues, 
and is an essential step in epidemiological studies. During economic growth, 
every society undergoes several substantial structural changes in healthcare 
demand and supply. In this paper, we discuss the relationship between 
economic growth and cancer incidences. The purposes is  to describe and 
measure the influence of an increasing per capita income on the overall 
incidence of cancer. By using worldwide cross-sectional data from 162 
countries, regression results with crude and age-standardised rates, allows us to 
measure the elasticity of cancer incidences with respect to per capita income 
and to decompose the elasticity coefficient into two components: age-effect and 
lifestyle-effect. In this article we sketch a macroeconomic theory of cancer 
incidence. We introduce some basic hypotheses about how demand-side 
economic structural changes may affect the evolution of cancer incidence. 
Finally, we try to develop a basic framework in order to explain how economic 
structural changes on the demand-side can affect the evolution of cancer 
incidence. 
Keywords: cancer incidence; economic growth; structural change; per-capita 
income; lifestyle effect; age effect. 
Reference to this paper should be made as follows: Cruickshank, S.,  
McIntosh, B. and Fascia, M. (xxxx) ‘Dismay and disparities – economic 
development and cancer incidence’, Int. J. Healthcare Policy, Vol. X, No. Y, 
pp.xxx–xxx. 
Biographical notes: Susanne (Sue) Cruickshank is an Associate Professor in 
Cancer Nursing at the University of Stirling, Scotland, Chair of RCN Cancer 
and Breast Care Forum, member of the International Society of Nurses in 
Cancer Cares’ Corporate and Philanthropic Committee and editorial board for 
the RCNi Cancer Nursing Practice Journal. She has over 25 years of 
experience working in oncology and haematology clinically and her research 
portfolio focuses on interdisciplinary, clinically applied research that seeks to 
improve care, irrespective of setting. 
   
 
   
   
 
   
   
 
   
   2 S. Cruickshank et al.    
 
    
 
 
   
   
 
   
   
 
   
       
 
Bryan McIntosh has worked at the central government, NHS, local government 
and various academic institutions within the UK. These include University of 
Westminster, University of Surrey, University of Greenwich and King’s 
College London. He is the Consultant Editor of the British Journal of 
Healthcare Management dealing directly with commissioning and content. He 
has an extensive publication record in peer reviewed journals and has worked 
extensively within the field of health management consultancy. 
Michael Fascia is a former (Hon.) Fellow in the College of Medicine and 
Veterinary Medicine at the University of Edinburgh from 2014–2016, and a 
former Senior Manager and government steering group member within NHS 
Scotland where he led development of the Chronic Pain Service from  
2013–2015. He is the Director of Research at the Edinburgh Multicultural 
Research Institute and an editorial board member for the highly prestigious 
British Journal of Healthcare Management. He is the current L’Arche 
Research Fellow within the Edinburgh community and a patron of Pain 
Association Scotland. Elements of his research also reflect on environmental 
sciences, association and prediction methods, leadership theory, primary and 
secondary care analysis, business development methods, and organisation 




Quantifying cancer occurrences in a given population is therefore an essential step in 
epidemiological studies. During economic growth, however, every society undergoes 
several substantial structural changes in healthcare demand and supply. These changes 
modify both composition and priority of society’s health problems. Cancers: “…that once 
were rare and considered the diseases of western countries … are now frequently 
diagnosed in less developed or economically transitioning countries and their rates are on 
the rise” (Jemal et al., 2010). 
Understanding how cancer incidence evolves during economic growth is increasingly 
useful for forecasting the economic impact of cancerous diseases, and for governing the 
process of resource allocation in planning health services. In this article, we sketch a 
macroeconomic theory of cancer incidence. We introduce some basic hypotheses about 
how demand-side economic structural changes may affect the evolution of cancer 
incidence. The purpose of this study is to simply highlight some theoretical insights to be 
considered for further research. This is in order to start developing an economic theory of 
cancer incidence. 
Quality of life is a multidimensional construct with many outcomes of many different 
variables. Some of these variables, however, show a positive and significant correlation 
with per capita income, usually measured by the ratio of real gross national income (GNI) 
to population. This is why the real GNI per capita is often used as the first and basic 
indicator of standard of living. Health is a fundamental dimension of quality of life. In 
fact, almost all indices of economic and social well-being contain at least one variable for 
measuring health conditions. There are some important exceptions, but in the long-run, 
higher values of real per capita income usually correspond to better hygiene and sanitary 
conditions. During growth, however, each society undergoes several important changes 
in both demand and supply of health care. Therefore, the process of economic growth 
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modifies the composition and order of importance of the main population which modifies 
the hierarchy of health needs within a population. 
This paper analyses one of the foremost of these changes with society’s health 
problems and focuses on the relationship between economic growth and cancer 
incidence. In particular, we explore this relationship at the macroeconomic level, using 
worldwide cross-sectional data from 162 countries in 2012. First, we attempt to collect 
some empirical regularity concerning how an increasing real per capita income influences 
the overall incidence of cancer. Second, we use these results to introduce some basic 
hypotheses about how the demand-side economic structural changes can affect the 
evolution of cancer incidence in a given population. 
Understanding and measuring how cancer incidence evolves during economic growth 
can be useful for forecasting the economic impact of cancer and for governing the 
process of resource allocation in planning health services. However, it is necessary to 
emphasise that this is not a study about social and economic factors causing cancerous 
conditions. This paper simply highlights some basic empirical regularities and theoretical 
insights to be considered for further research in order to develop an economic theory of 
cancer incidence. 
The remainder of the paper is organised as follows. Firstly, an introduction of the 
three essential measures of cancer frequency. Secondly, a discussion to confirm the value 
of quantitative analysis. Thirdly, a review of cancer incidence theory within a structural 
economic dynamic framework. Finally, the paper concludes with some suggestions for 
further research. 
2 Cancer risk factor and cancer incidence 
In order to describe and measure the frequency of cancerous diseases, epidemiology 
utilises three main indicators: incidence, prevalence and mortality. Incidence and 
mortality are flow variables. They indicate the number of new cancer cases and the 
number of deaths due to cancer, respectively, which occur in a specific population over a 
given period (usually one year). Prevalence is a stock variable. It indicates the number of 
cancer cases in a specific population at a given point in time (Last, 2001). 
Data on incidence, prevalence and mortality are usually expressed as absolute 
numbers or as rates. Rates can be crude or age-standardised. A crude rate (cr) is 
calculated by dividing the absolute number of new cases, current cases or deaths by the 
corresponding number of people in the population-at-risk. On the other hand, an  
age-standardised rate (ASR) (sr) is a weighted average of the age-specific crude rates, 
where the weights are the proportion of people in the corresponding age groups of a 
specific standard population. Since cancer is not a single disease but a collection of 
diverse yet related diseases, the population-at-risk is a subset of the total population under 
study (usually defined by gender and age) that include only the people who are 
potentially susceptible to develop one or the group of cancerous diseases under 
consideration. The age-adjusted rates are calculated to allow comparison between 
populations with different age structures (results are usually presented as annual rates per 
100,000 persons-at-risk) and they are particularly useful in making international 
comparisons. 
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Where raw data are regularly collected by local cancer registry, these basic measures 
of cancer frequency can be computed for each type of cancer, usually classified according 
to the International Classification of Diseases (ICD) or for all cancerous diseases as a 
whole (WHO, 2015). In the latter case, epidemiologists usually refer to the overall 
prevalence rate as a measure of society’s cancer burden. In the same way, since incidence 
is regarded as a useful approximation to the average risk of developing any type of 
cancer, the overall incidence rate is considered as an index of the level of cancer risk 
factors that exist in a given society, during a given period. Finally, the overall mortality 
rate provides an approximation to the average risk of dying from some type of cancer. 
The term cancer refers to a broad group of diseases in which normal cells of a specific 
tissue changes and begin to not function properly. In particular, mutated cells do not 
respond to regular cell cycle control signals and begin to grow and divide in an 
uncontrolled way. This population of abnormal cells is able to invade and destroy other 
nearby tissues and also to spread to other parts of the body, causing severe illness and 
death. 
Although all cancerous diseases begin in cells with some kind of damage in genetic 
material, there is not one single factor to cause a healthy cell to become cancerous. 
Cancer is likely to be influenced by many variables. Different types of cancer usually 
share some basic causes and at the same time each type of cancer has its own specific 
determinants. The transformation from a normal cell into a cancer cell is indeed a 
multistage and complex process. According to a large literature on cancer aetiology, 
however, this process is the result of the interaction between the inborn genetic 
characteristics of each individual and numerous external causes that can be gathered and 
classified into three main categories: biological, chemical and physical carcinogens 
agents. 
Genetic characteristics, along with external carcinogens agents, determine a set of 
cancer risk factors. A cancer risk factor is anything that may increase an individual’s 
probability of developing some type of cancer. A risk factor itself does not necessarily 
cause the disease. Nevertheless, the frequency of cancers in a specific population is 
associated, ceteris paribus, with the intensity and the duration of people’s exposures to 
one or more risk factors. Furthermore, as in other non-communicable diseases, there is a 
delay between the illness onset and the exposure to risk factors that is ‘today’s incidence 
rate affected by yesterday’s exposure and today’s exposure affecting tomorrow’s 
incidence rate’. 
The subset of the external carcinogens agents is strictly related to the general 
environmental and socio-economic conditions, as well as population habits and customs. 
Epidemiological studies suggest a long list of behaviours and situations associated with 
an increased cancer incidence. Tobacco and excessive alcohol consumption, qualitative 
and quantitative unhealthy nutrition, chemical contamination of food, air and water, lack 
of physical activity, unprotected exposure to ultraviolet and ionising radiation and 
chronic infection from some viruses are the main factors which play an important role in 
causing cancers. However, people can still get skin cancer if wearing sun cream even if 
superficially protected from ionising radiation they are still exposed 
By affecting the individual and giving them a chance to acquire this disease, all  
non-congenital cancer risk factors, taken as a whole, is a leading force that contributes to 
determine the overall rate of cancer incidence in a given population. A distinctive feature 
of these external cancer risk factors is that, at least partially, they are avoidable. Each 
combination of behaviours and situations are associated with a low or a high risk to 
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developing any type of cancer, reflecting on a given healthy or unhealthy lifestyle. 
Therefore, the population exposure to cancer risk factors change when people modify 
their habits and customs, both directly via individual choices (such as variations in 
dietary components and eating patterns) and/or indirectly by means of collective choices 
(such as changes in regulations of environmental pollution and workplace conditions). 
3 International evidence 
Economic growth can affect cancer incidence, prevalence and mortality in various ways. 
In this paper we focus on the influence of a long-term increase in real per capita income 
on the overall incidence rate of all types of cancer. 
Table 1 Variables and summary statistics 
Description Variable Mean Std. dev. Min Max 
World group (n = 162) 
Per capita gross national income Y 8,166.90 8,937.60 500.00 37,270.00 
Total (female and male), 
incidence crude rate 
TCR 183.83 139.25 44.70 507.99 
Female, incidence crude rate FCR 178.45 124.30 58.90 496.40 
Female, incidence  
age-standardised rate 
FASR 163.03 53.30 77.90 308.70 
Male, incidence crude rate MCR 190.24 156.56 36.00 585.80 
Male, incidence  
age-standardised rate 
MASR 187.67 80.30 64.90 406.60 
Western group (n = 41) 
Per capita gross national income Y 18,515.00 10,325.70 1,620.00 37,270.00 
Total (female and male), 
incidence crude rate 
TCR 388.02 85.18 198.09 507.99 
Female, incidence crude rate FCR 359.98 78.71 196.70 496.40 
Female, incidence  
age-standardised rate 
FASR 224.04 40.51 160.60 308.70 
Male, incidence crude rate MCR 419.35 98.78 196.00 585.80 
Male, incidence  
age-standardised rate 
MASR 290.26 47.89 206.50 406.60 
Notes: Y, current international dollars, purchasing power parity (PPP), 2012  
(WB, 2014). 
CR and ASR, crude and ARSs for all types of cancers: all sites but non-melanoma 
skin (C00-C96, but C44, International Classification of Diseases – ICD). 
Incidence rates per 100,000 persons, 2012 (IARC, 2004). 
Countries in the ‘Western group’: Albania, Austria, Belarus, Belgium, Bosnia and 
Herzegovina, Bulgaria, Croatia, Czech rep. Denmark, Estonia, Finland, France, 
Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta 
Netherlands, Norway, Poland, Portugal, Rep. Moldova, Romania, Russian Fed., 
Serbia and Mont., Slovakia Slovenia, Spain. Sweden, Switzerland, TFYR 
Macedonia, the UK, Ukraine, Australia, Canada, New Zealand, and the USA. 
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Using data from the World Bank (WB) and the World Health Organization (WHO), we 
developed an empirical analysis of the relationship between economic growth and cancer 
incidence. For this purpose, we use cross-sectional data on per capita income and cancer 
incidence in 201 from 16 countries including the WB and WHO statistical databases, and 
for a subset of these 16 countries, which consist of a more homogeneous group of 41 
countries, that are characterised by a ‘Western lifestyle’. In this subset there are 36 
European countries plus Australia, Canada, New Zealand and the USA (from now, we 
simply refer to the whole set as the world group and to the subset as the Western group). 
More particularly, real per capita income is measured by the ratio of GNI to 
population and it is expressed in current international dollars, using purchasing power 
parity (PPP) rates (WB, 2014). Cancer incidence is measured by the crude and the  
ARSs of all types of cancer (“all sites, excluding non-melanoma skin”, according to the 
ICD classification) provided by the WHO within Globocan project (Bray et al. 2004). In 
fact, International Agency for Research on Cancer (IARC) publishes free software with 
worldwide estimation of cancer incidence, prevalence and mortality. For cancer 
incidence, these data include absolute numbers of new cancer cases and crude and ARSs, 
in both the male and female population. 
Table 1 contains a short description and some basic descriptive statistics of all 
variables for the two groups of countries (the complete database is available from the 
author). 
As a useful starting point to highlight this issue, in Figures 1 and 2, the crude rate of 
incidence of all types of cancers within the total population (TCR) is plotted against the 
per capita income (Y) for all 162 countries and for the subset of 41 countries. Both scatter 
plots seem to suggest a strong influence of real per capita income on the average risk of 
developing some type of cancer. 
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In order to measure the magnitude of this influence, Tables 2 and 3 show the results of 
ordinary least square (OLS) estimations of the relationship TCR = f(Y) in three different 
specifications: linear, quadratic and double-log. The goodness of fit is fairly high in all 
equations. The crude rate shows a strong positive and significant relationship with per 
capita income, but it tends to increase less than proportionally with respect to Y. In other 
words, during economic growth the crude rate of cancer incidence increases, but it 
evolves drawing approximately the early stage of an inverted U-shaped curve. Indeed, the 
quadratic and double-log forms are the two specifications that best fit data for the world 
and Western groups, respectively. 
This analysis, however, neglects the powerful influence of gender and age on cancer 
incidence. Thus, it is necessary to repeat OLS estimation using crude and ASR, in both 
the male and female populations (again in linear, quadratic and double-log 
specifications). 
The simple decomposition of crude rate by gender does not alter the previous results 
(as shown in Tables 2 and 3). Instead, using ARSs there is a slight reduction in the 
goodness of fit. Changes in per capita income, however, continue to explain an important 
part of the change in cancer incidence. This effect is not due to the positive influence of 
economic growth on the average duration of life. 
In particular, a straight line best describes the relationship between real per capita 
income and cancer incidence within the female population in both groups of data, while 
quadratic and double-log forms provide a reasonably close approximation of data for the 
male population in countries within the world and Western groups, respectively. All this 
seems to confirm a relevant negative effect of economic growth on the presence of cancer 
risk factors in different populations. 
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3.1 Income elasticity of cancer incidence 
These results suggest that economic growth has a negative influence on cancer incidence, 
but they also indicate that in some cases cancer incidence tends to rise less than 
proportionally with respect to the increase in real per capita income. Moreover, the 
negative effect of economic growth on the overall rate of cancer incidence seems to be 
only partially related to the implications of an ageing population. Results of our 
regressions on crude and ARSs indicate that there are both gross and net effects of 
economic growth on cancer incidence, respectively. 
Regression models using the double-log specifications allow us to easily calculate the 
elasticity of cancer incidence with respect to real per capita income. These coefficients 
provide an idea of the dimensions of both gross and net effects of economic growth on 
cancer incidence. 
Table 4 Elasticties and income turning points 
Variable World elasticity 




Western Y*, PPP 
(2012) 
1 TCR 0.508 44.053 0.270 31.452 
2 FCR 0.462 45.773 0.265 34.642 
3 MCR 0.558 42.697 0.280 29.548 
Mean CR 0.510 44.235 0.273 32.095 
4 FASR 0.184 -- 0.178 -- 
5 MASR 0.273 33.632 0.146 35.532 
Mean ASR 0.229 -- 0.162 -- 
All observations 
mean 
0.397 41.539 0.228 32.793 
Std. dev. 0.151 4.845 0.058 2.431 
As shown in Table 4, all elasticities are positive but less than one. On average, the 
coefficient is about 0.4 for countries within the world group and 0.2 for those within the 
Western group. Differences in elasticity between these two groups are mainly due to the 
effect of economic growth on the average life expectations at birth. As a matter of fact, 
using the ARSs, cancer incidence increases on average by 0.23% and 0.16% in the world 
and Western groups, respectively, for each 1% increase in real per capita income. 
Finally, using regression results from the quadratic specification, we can calculate the 
average hypothetical threshold level of Y (that is, the real per capita income beyond 
which cancer incidence starts diminishing, Y*). As shown in Table 4, in a long-run 
perspective, the process of economic growth may tend to exhaust the strong net negative 
effect on cancer incidence. However, our results within the male population indicate that 
this threshold level of real per capita income is extremely high (about $33,000 and 
$35,000 for the world and Western groups, respectively). 
3.2. Economic growth, structural change and cancer incidence 
Abstracting from the complexity of the causal interactions between different carcinogen 
agents and the process of cancer initiation and progression at a macroeconomic level, the 
relationship between cancer incidence and lifestyle-related factors may be described by a 
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simple model, like: isr = f(q; α), where the ARS of incidence for all types of cancer (isr) 
in a given population, at time tn, depend on the people’s exposure to external cancer risk 
factors (q), at time t0, for a stated level of unavoidable agents due to the individuals’ 
genetic characteristics (α). 
Here q is a catchall variable that stands for all the behaviours and situations that 
characterise people’s habits and customs and it serves as a proxy for measuring the 
average population exposure to lifestyle cancer risk factors. One may think q as a bundle 
of low risk (such as foods) and/or high risk (such as environmental pollutions), in which 
each item is described by the set of its healthy related attributes for instance, the safety 
and nutritional characteristics of foods that reflect a poor or healthy eating habits. The 
whole set of these attributes determines more or a less cancer risk prone lifestyle. 
In the short run, changes in relative prices may have some influence on q, but its main 
composition is likely to be constant. On the other hand, in the long run the average 
population exposure to external cancer risk factors tends to undergo dramatic structural 
changes. In particular, as real per capita income increases there are successive income 
threshold levels where people shift their behaviours and start following a new lifestyle. In 
each stage of development, the population consumption pattern follows a hierarchy of 
needs and wants (determined by many biological, cultural and social factors), so that as 
the average income rises, increases in consumption tends to concentrate on a particular 
group of goods with specific characteristics and this group changes, sometimes gradually 
and sometimes abruptly, from one level of real per capita income to another. 
‘Engel’s law’, states that the proportion of income spent on each type of goods 
changes as real average income increases. This is due to people modifying their 
preferences, by means of both individual and collective choices, along a distinct 
hierarchy of needs. Put differently, an increasing purchasing power deeply modifies 
people habits and customs. These changes in lifestyles cause transformations of the set of 
attributes that enter the bundle of health-related low risk (and high risk) faced by the 
population, and therefore they have strong effects on population health-related 
consumption patterns. 
An aggregate Engel’s function, in which the average people exposure to external 
cancer risk factors (q) depends on the population real average income (y) like: q = g(y), 
albeit very simple, may be a useful tool to capture the influences of economic growth on 
cancer incidence. In effect, replacing q in isr = f(q; α) by its expression from q = g(y), 
gives: isr = f [g(y); α]. That is a relation between real per capita income, at time t0, and 
the ARS of incidence at time tn, for a given level of the unavoidable cancer risk factors, 
α. 
At the microeconomic level, many studies have examined how personal income and 
wealth can influence individual exposure to cancer risk factors. On the contrary, 
macroeconomic analysis of this issue seems to be a relatively underdeveloped area of 
research. Previous studies in this field have highlighted that the evolution of cancer 
incidence in a growing economy is a very complex subject that should be approached in 
an interdisciplinary framework (Ukraintseva and Yashin, 2005). To contribute to this 
aim, here, we develop a very basic economic model that can provide some insights into 
building a more realistic and complex theory (Bosanquet and Sikora, 2006). 
As in other stock-flow relationships, a given average duration of the disease 
prevalence is a function of the incidence and mortality rates. In the following discussion, 
this kind of stock–flow relationship allows us to simply focus on cancer incidence and 
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mortality, in order to develop an elementary framework where, ceteris paribus, changes 
in mortality and incidence rates during economic growth are primarily due to structural 
changes operating on the supply and demand sides of the economy, respectively. 
More particularly, on the supply side, as real GNI per capita income increases, better 
medical and surgical treatments become available, and notably, better techniques for 
early diagnosis. All these technical changes can dramatically reduce cancer mortality. 
This is why, all other things being equal, for a given incidence rate, economic growth 
implies a notable increase in prevalence rates (Capocaccia et al., 2002). In contrast, on 
the demand side of the economy, long-run increases in real per capita income tend to 
raise the average life expectations at birth. Since the average risk of developing any type 
of cancer is strongly influenced by age, economic growth may lead to an increase in the 
overall incidence rate of cancerous diseases. 
In this paper we focus only on the demand side effects of economic growth on cancer 
incidence. Economic and social structural changes that characterise the processes of 
economic growth deeply modify the population’s habits and lifestyles. Studies on cancer 
aetiology point out the multifactorial nature of these types of diseases and the great 
importance of habits and lifestyles as risk factors (Nasca, 2007). As a result, economic 
growth tends to modify population exposure to cancer risk factors (such as, nutritional 
and environmental risk factors). 
Considering these structural changes from the demand side of the economy, an 
Engel’s function may be a simple, but very useful tool for analysing how cancer 
incidence changes during economic growth. From this perspective, exposure to cancer 
risk factors can be thought as the consequence of the characteristics of goods and services 
that enter the average consumption bundle demanded by the representative consumer at 
each stage of economic growth. 
If there is something that we positively know about the expansion of per capita 
demand when real income increases, it is that per capita demand for each commodity 
usually does not increase proportionally (Pasinetti, 1981). This is a well-known 
generalisation of Engel’s law: it simply states that the proportion of income spent on each 
type of goods and services changes as real per capita income increases because 
consumers increase consumption along a hierarchy of needs. Therefore, during economic 
growth the composition of the average consumption bundle demanded by the 
representative consumer changes continually over time. 
For our purposes, it is useful to think of a consumption bundle of goods and services 
(QAC) that reflects a lifestyle characterised by a low risk of developing any type of 
cancerous diseases (i.e., an anti-cancer lifestyle, noting this would not reduce risk of 
genetically linked cancers – cancer-risk reducing lifestyle). In the presence of a hierarchy 
of needs (determined by biological, cultural and social factors), even the demand for the 
QAC consumption bundle does not increase proportionally. With regard to how the 
demand for an anti-cancer lifestyle consumption bundle increases in a growing economy, 
it seems reasonable to introduce some basic hypotheses (Figure 3). In the early stages of 
economic growth, the demand for a healthy lifestyle is likely to be close to zero and it 
may tend to increase less than proportional with respect to real per capita income (Y). 
However, in the subsequent stages of growth, real per capita income increases demand 
and income may be linearly related. Finally, after real per capita income reaches a 
threshold level (Y''), the demand for an anti-cancer lifestyle may tend to increase more 
than proportionally. 
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Figure 3 Engel’s curve 
 QAC 
QAC = f (Y) 
Y’ Y’’ Y 
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Y, GNI per ca pita (current interna tio nal dollars, PPP)  
Source: WHO (2005) 
Epidemiological data on tobacco consumption, for example, seems to support this 
hypothesis. In Figure 4, the age-standardised prevalence of current tobacco smoking 
among adults is plotted against the real per capita income, for a set of 118 countries 
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(WHO, 2017). The scatter plot confirms that anti-cancer lifestyle behaves like a luxury 
good. At lower per capita income, economic growth pushes up tobacco consumption. 
Prevalence rate of current tobacco smoking is positive related to economic growth until 
about $15,000. After this threshold level, tobacco becomes an inferior good and the  
age-standardised prevalence of current tobacco smoking starts declining. 
Figure 5 Kuznets’ curve 
ASR 
ASR* 
ASR = g(Y) 
ASR° 
Y’ Y’’ Y* Y  
From the Engel’s curve depicted in Figure 3, we can derive a function that describes how, 
ceteris paribus, the overall cancer incidence evolves in a growing economy.  
Figure 5 shows a possible general form of this relationship, in which cancer incidence is 
measured by the ASR and economic growth is measured by the real per capita income 
(Y). It is interesting to note that the relationship assumes the form of a type of Kuznets 
curve (Kuznets, 1955). Increases in real per capita income have a more-than-proportional 
negative effect on the overall cancer incidence only in the early stages of economic 
growth. During growth, as a result of the expansion of demand for the anti-cancer 
lifestyle consumption bundle, this more-than-proportional relationship tends to disappear. 
In particular, if a healthy lifestyle is a luxury good, after the early stages of economic 
growth the overall incidence rate will increase, but less than proportional with respect to 
Y (there also can be an interval of the growth process where the ARS of cancer incidence 
rises approximately linearly with per capita income). 
Furthermore, the relationship between overall cancer incidence and real per capita 
income has a positive intercept on the y-axis and a turning point. In particular, ASR° 
measures the autonomous component of the incidence rate (namely, the component that 
is independent of income because it is weakly influenced by exposure to risk factors, 
such as in the type of cancer with an important genetic and/or infective aetiology) and Y* 
is the threshold level of per capita income beyond which cancer incidence starts 
diminishing. 
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4 Impact of life expectancy with increase in economic wealth 
Economic growth affects cancer incidence, prevalence and mortality in various ways. In 
particular, at macroeconomic level, changes in cancer frequency are primarily due to 
some relevant structural changes operating on the supply and demand side of the 
economy, respectively. 
On the supply side, as the growth process progresses, better medical and surgical 
treatments, and notably, better techniques for early diagnosis become available (and 
usually affordable) to a large proportion of the population. These medical improvements 
are able to dramatically reduce the mortality of cancers. Improvements in healthcare 
provision across all diseases will impact on cancer prevalence as people live longer and 
survive other diseases such as cardiac failure, their risk of developing cancer increases, 
i.e., they survive long enough to get it rather than dying at a younger age from something 
else. Arguably, this is why in each society, all other things being equal, for a given 
incidence rate economic growth implies a notable increase in prevalence rates. However, 
the supply-side influences of economic growth may also be negative. In fact, the new 
products and production processes discovered in the past sometimes reveal harmful 
effects, and therefore affect today’s incidence rates. 
On the demand side, it is useful to denote with qLOW and qHIGH two specific 
combinations of the risk-increasing and risk-reducing aspects that reflects a lifestyle 
characterised by low and high risk of developing any type of cancer, respectively. 
Specifically, qLOW indicates a set of behaviours and situations associated with a 
minimum level of the average population exposure to the external cancer risk factors, and 
vice versa for qHIGH. It seems reasonable to think at qLOW (that is, to think at ‘an anti-
cancer lifestyle’) as a luxury good, with an income elasticity greater than one, and at 
qHIGH as a normal (or inferior) good, that is a good with an income elasticity positive, 
but always less than one (or negative, in the case of a good). 
In general, because of the existence of a hierarchy of needs, one observes that the 
demand for a luxury good, at aggregate level, tends to remain weak until real average 
income reaches a threshold critical level, and after that it starts to increase sharply. By 
affecting the demand for qLOW and qHIGH, economic growth modifies the average 
composition of q, positively (i.e., towards qLOW) or negatively (i.e., towards qHIGH) 
and in turn it changes the average population exposure to external cancer risk factors. 
At less developed stages of social and economic conditions the process of growth 
usually pushes populations towards an unhealthy ‘western lifestyle’, such as smoking and 
consumption of calorie-dense food. Furthermore, in these circumstances economic 
growth is often driven by an industrialisation process based upon high polluting 
production methods, that typically takes place in unsafe and harmful working 
environments. As growth progresses and the average income overcomes a threshold 
level, changes in both individual and collective preferences lead to an increase in demand 
for an healthy lifestyle. As a result, the effects of economic growth on cancer incidence 
gradually turn from negative to positive. 
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5 Conclusions 
Cancer incidence depends on the population exposure to external cancer risk factors 
which, in turn, depends on the level of development. Changes in income, therefore, lead 
to changes in lifestyle and thus to changes in new cancer cases. 
At theoretical level, some kind of J-curve is a possible general model to represent, all 
other things being equal, how economic growth influences cancer incidence in a given 
homogeneous population. This complex relationship may be captured by some basic 
hypotheses, as illustrated in Figure 6, where cancer incidence is measured by the ARS of 
all types of cancer (isr) at time tn and economic growth is measured by the real per capita 
income (y) at time t0. 
Figure 6 Cancer J curve (see online version for colours) 
 
At very low-income levels, there is often a high incidence of cancers related to some 
biological (i.e., infectious) agents. Until y1, the positive effects of economic growth on 
general hygiene and sanitary conditions lead to a decrease in the future overall rate of 
cancer incidence. However, there will be a threshold minimum level that measures the 
autonomous component of the incidence rate (that is, isrMIN is independent of income, 
because it is weakly influenced by exposure to external risk factors, such as in the type of 
cancers with an important genetic aetiology). 
Beyond y1, cancer incidence will rise with economic growth. More specifically, there 
is an early range of development stages (from y1 to y*) in which increases in real per 
capita income have a more-than-proportional negative effect on the overall rate of cancer 
incidence. When average income became greater than y* as a result of the expansion of 
demand for a lifestyle that reduces the risk of cancer, this more-than-proportional 
relationship tends to disappear. Cancer incidence will continue to rise but less than 
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proportional with respect to y. Economic growth returns to exert a positive effect on 
population exposure to external cancer risk factors only after y**, where isr reaches its 
maximum. Finally, when the development stages pass this threshold level, the overall rate 
of age-standardised cancer incidence might start decreasing. 
Describing and measuring the relationship between cancer incidence and real per 
capita income constitutes the first step in understanding how the process of economic 
growth affects population exposure to cancer causing factors. In fact, real per capita 
income is not an accurate and adequate measure of a country’s level of development and 
it is not possible to summarise in Y a set of economic, social and health features. Further 
research is needed to include more variables, for example, those referring to personal 
income distribution, cultural habits and customs, general sanitary conditions and health 
policies. It is also necessary to utilise epidemiological data for each type of cancer within 
more homogeneous genetic populations. 
This paper, however, highlights some basic empirical regularities and theoretical 
insights that may be useful in developing an economic theory of the evolution of cancer 
incidence in a growing economy. 
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